Titan Medical (NSDQ:TMDI) said today that it has achieved a design freeze for its single-port Sport robotic surgery platform.
The Toronto-based company said that the freeze is the culmination of engineering work based on feedback it received through extensive preclinical feasibility studies and an ongoing formative human factors study.
Read the whole story on our sister site, Medical Design & Outsourcing
